Literature DB >> 25405805

Virology, immunology and pathology of human rabies during treatment.

Yolanda Caicedo1, Andres Paez, Ivan Kuzmin, Michael Niezgoda, Lillian A Orciari, Pamela A Yager, Sergio Recuenco, Richard Franka, Andres Velasco-Villa, Rodney E Willoughby.   

Abstract

BACKGROUND: Rabies is an acute fatal encephalitis caused by all members of the Lyssavirus genus. The first human rabies survivor without benefit of prior vaccination was reported from Milwaukee in 2005. We report a second unvaccinated patient who showed early recovery from rabies and then died accidentally during convalescence, providing an unparalleled opportunity to examine the histopathology as well as immune and virological correlates of early recovery from human rabies.
METHODS: Case report, rapid fluorescent focus inhibition test, enzyme-linked immunosorbent assay, indirect and direct fluorescent antibody assays, reverse-transcriptase polymerase chain reaction, phylogenetic reconstruction, isolation in tissue culture, pathology and immunohistochemistry.
RESULTS: The 9 year old died 76 days after presenting with rabies of vampire bat phylogeny transmitted by cat bite. Antibody response in serum and cerebrospinal fluid was robust and associated with severe cerebral edema. No rabies virus was cultured at autopsy. Rabies virus antigen was atypical in size and distribution. Rabies virus genome was present in neocortex but absent in brainstem.
CONCLUSIONS: Clinical recovery was associated with detection of neutralizing antibody and clearance of infectious rabies virus in the central nervous system by 76 days but not clearance of detectable viral subcomponents such as nucleoprotein antigen or RNA in brain.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25405805      PMCID: PMC4809748          DOI: 10.1097/INF.0000000000000624

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  37 in total

1.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

2.  Survival of a rabies patient.

Authors:  Ashok Kumar Rawat; Sunil Kumar Rao
Journal:  Indian Pediatr       Date:  2011-07       Impact factor: 1.411

3.  Massive necrosis of the brain in rabies.

Authors:  C L Dolman; K M Charlton
Journal:  Can J Neurol Sci       Date:  1987-05       Impact factor: 2.104

4.  A case of human rabies with prolonged survival.

Authors:  R W Emmons; L L Leonard; F DeGenaro; E S Protas; P L Bazeley; S T Giammona; K Sturckow
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

5.  Recovery of a patient from clinical rabies--California, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-02-03       Impact factor: 17.586

6.  Transmission of rabies virus from an organ donor to four transplant recipients.

Authors:  Arjun Srinivasan; Elizabeth C Burton; Matthew J Kuehnert; Charles Rupprecht; William L Sutker; Thomas G Ksiazek; Christopher D Paddock; Jeannette Guarner; Wun-Ju Shieh; Cynthia Goldsmith; Cathleen A Hanlon; James Zoretic; Bernard Fischbach; Michael Niezgoda; Waleed H El-Feky; Lillian Orciari; Edmund Q Sanchez; Anna Likos; Goran B Klintmalm; Denise Cardo; James LeDuc; Mary E Chamberland; Daniel B Jernigan; Sherif R Zaki
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

7.  Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies.

Authors:  Jiraporn Laothamatas; Supaporn Wacharapluesadee; Boonlert Lumlertdacha; Sumate Ampawong; Vera Tepsumethanon; Shanop Shuangshoti; Patta Phumesin; Sawwanee Asavaphatiboon; Ladawan Worapruekjaru; Yingyos Avihingsanon; Nipan Israsena; Monique Lafon; Henry Wilde; Thiravat Hemachudha
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

8.  Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.

Authors:  B Dietzschold; M Kao; Y M Zheng; Z Y Chen; G Maul; Z F Fu; C E Rupprecht; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Presence of cross-reactions with other viral encephalitides in the indirect fluorescent-antibody test for diagnosis of rabies.

Authors:  Robert J Rudd; Kim A Appler; Susan J Wong
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

10.  Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

Authors:  D C Hooper; K Morimoto; M Bette; E Weihe; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  4 in total

1.  Human rabies postexposure prophylaxis and rabid terrestrial animals in Ontario, Canada: 2014-2016.

Authors:  D Middleton; L Friedman; S Johnson; S Buchan; B Warshawsky
Journal:  Can Commun Dis Rep       Date:  2019-07-04

Review 2.  Management of Viral Central Nervous System Infections: A Primer for Clinicians.

Authors:  P Brandon Bookstaver; Phillip L Mohorn; Ansal Shah; Lauren D Tesh; April M Quidley; Ravish Kothari; Christopher M Bland; Sharon Weissman
Journal:  J Cent Nerv Syst Dis       Date:  2017-05-01

3.  Using the LN34 Pan-Lyssavirus Real-Time RT-PCR Assay for Rabies Diagnosis and Rapid Genetic Typing from Formalin-Fixed Human Brain Tissue.

Authors:  Rene Edgar Condori; Michael Niezgoda; Griselda Lopez; Carmen Acosta Matos; Elinna Diaz Mateo; Crystal Gigante; Claire Hartloge; Altagracia Pereira Filpo; Joseph Haim; Panayampalli Subbian Satheshkumar; Brett Petersen; Ryan Wallace; Victoria Olson; Yu Li
Journal:  Viruses       Date:  2020-01-18       Impact factor: 5.048

4.  Comparing clinical protocols for the treatment of human rabies: the Milwaukee protocol and the Brazilian protocol (Recife).

Authors:  Leandro Augusto Ledesma; Elba Regina Sampaio Lemos; Marco Aurélio Horta
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.